Monday, 09 December 2019

World News

  • Study shows malaria in Africa is developing resistance to drugs

    World |  News | 0 Comment | 23 Apr, 2018

    Singapore - Annual deaths from malaria are decreasing, but the disease is still a global health problem, with 216 million new cases estimated in 2016 alone. The emergence of drug resistance...Read more

  • Novartis appoints John Tsai as Head GDD, CMO

    World |  News | 0 Comment | 21 Apr, 2018

    Novartis has announced the appointment of John Tsai, M.D. as Head of Global Drug Development (GDD) and Chief Medical Officer. Dr. Tsai will join Novartis on May 1, 2018, and will be based i...Read more

  • UCB to acquire Proximagen’s midazolam nasal spray

    World |  News | 0 Comment | 20 Apr, 2018

    Singapore- Belgium based UCB announced an agreement to acquire the rights to Proximagen's Midazolam Nasal Spray (USL261), an anti-epilepsy drug (AED) developed as an intended rescue tr...Read more

  • myAirvo significantly benefits COPD Patients

    World |  News | 0 Comment | 20 Apr, 2018

    Singapore- Fisher & Paykel Healthcare Corporation Limited announced that new research has been published in the International Journal of COPD which demonstrates significant benefit...Read more

  • Axsome appoints Nick Pizzie as CFO

    World |  News | 0 Comment | 20 Apr, 2018

    Singapore- Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, announced the appointment...Read more

  • GSK appoints Kevin Sin as SVP, Global Research Head

    World |  News | 0 Comment | 20 Apr, 2018

    GlaxoSmithKline (GSK) has announced the appointment of Kevin Sin as Senior Vice President and Head of Worldwide Business Development for Pharmaceuticals Research & Development. In this ...Read more

  • P&G to acquire Merck KGaA consumer health unit

    World |  News | 0 Comment | 19 Apr, 2018

    Singapore- Procter & Gamble has confirmed that it has signed a deal to acquire the Consumer Health business of Merck KGaA for €3.4 billion -- about $4.21 billion, one of the c...Read more

  • New commercial chief at Ra Pharma

    World |  News | 0 Comment | 19 Apr, 2018

    Singapore- Ra Pharmaceuticals, a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, anno...Read more

  • J&J ramps up pricing for Imbruvica

    World |  News | 0 Comment | 19 Apr, 2018

    Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) conveniently ahead of research that suggests the drug, which costs ~$148...Read more

  • Mundipharma expands partnership with Caris Life Sciences

    World |  News | 0 Comment | 18 Apr, 2018

    Mundipharma is partnering with Caris Life Sciences, a leading US biotechnology company, to provide the exclusive sales, promotion, marketing and distribution of its tumor profiling service,...Read more

  • Novartis to invest $100M for malaria elimination

    World |  News | 0 Comment | 18 Apr, 2018

    Novartis has announced a five-year commitment to the fight against malaria in conjunction with the 7th Multilateral Initiative on Malaria Conference and the Malaria Summit of the Commonweal...Read more

  • Sartorius Stedim Biotech, PSU announce partnership

    World |  News | 0 Comment | 18 Apr, 2018

    Sartorius Stedim Biotech and Penn State University (PSU) have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term re...Read more

  • GE launches new facility for viral vector based therapeutics

    World |  News | 0 Comment | 17 Apr, 2018

    GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and gene a...Read more

  • Shire offloads its oncology business for $2.4B

    World |  News | 0 Comment | 17 Apr, 2018

    Shire, a leading global biotechnology company focused on rare diseases is selling its oncology business to French drugmaker Servier S.A.S. for $2.4 billion. The US-based company said that t...Read more

  • Maternal metabolic factors and early-onset puberty may be related

    World |  News | 0 Comment | 16 Apr, 2018

    Singapore - In a study of more than 15,000 girls and their mothers — all Kaiser Permanente members in Northern California — maternal overweight and hyperglycemia were ...Read more

  • Major Italian sector federations showcase latest trends in healthcare

    World |  News | 0 Comment | 16 Apr, 2018

    Singapore – Nine major Italian federations representing sectors from fashion to healthcare and technology, arrived in Singapore to promote the “Made In Italy” label. ...Read more

  • UK team develops novel skin patch for diabetes

    World |  News | 0 Comment | 13 Apr, 2018

    A group of scientists at the University of Bath has created a non-invasive adhesive patch that promises the measurement of glucose levels through the skin without carrying out the pain...Read more

  • Merck to accelerate global access to affordable vaccines

    World |  News | 0 Comment | 13 Apr, 2018

    Merck, a leading science and technology company has announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturi...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls